FSH-secreting pituitary adenomas can affect sexual and reproductive function. In this article, we have reported the case of a 32-year-old male with secondary infertility. The patient had sexual and reproductive disturbances. The test results of the blood samples indicated obviously decreased testosterone (T) and estradiol (E2) levels. Based on previous hormonal results, the patient received pituitary stimulation and human chorionic gonadotropin (hCG) tests. Both follicle stimulating hormone (FSH) and luteinizing hormone (LH) showed low response during the pituitary stimulation test. The results of the hCG test indicated that T/E2 could recover to a normal level. In addition, this patient was diagnosed with pituitary macroadenoma, which was supported by the pituitary MRI. The man's sexual and reproductive functions recovered following surgery. The pathological results confirmed that the tumor tissue was an FSH-secreting pituitary adenoma by immunohistochemical staining. The purpose of this report was to review the relative literature and discuss the influence of FSH-secreting pituitary adenomas on hormones through the hypothalamus-pituitary-testis axis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973166 | PMC |
Publication Analysis
Top Keywords
Similar Publications
A FSH-secreting pituitary adenoma discovered after ovarian hyperstimulation syndrome: a case report, illustrating pitfalls in the interpretation of serum FSH levels.
BMC Womens Health
December 2024
Department of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki City, Osaka, 569-8686, Japan.
Background: Most cases of ovarian hyperstimulation syndrome (OHSS) are caused by infertility treatment using human menopausal gonadotropin (HMG) and human chorionic gonadotropin (hCG). OHSS is widely known to have a "spoke-wheel" appearance on imaging, presenting as bilateral symmetric enlargement of ovaries with multiple cysts of varying sizes. When this spoke-wheel appearance is observed in patients not undergoing infertility treatment, tumor-derived hormones such as follicle-stimulating hormone (FSH) and hCG should be measured.
View Article and Find Full Text PDFLow libido despite high normal testosterone levels in a male with an FSH-secreting pituitary macroadenoma.
Endocrinol Diabetes Metab Case Rep
January 2024
Department of Diabetes and Endocrinology, University Hospital Aintree, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Article Synopsis
- Functioning gonadotroph adenomas are rare tumors that secrete excess follicle-stimulating hormone (FSH) and often lead to sexual dysfunction and other symptoms before being diagnosed.
- A case study highlighted a 37-year-old male with FSH-secreting macroadenoma who experienced sexual difficulties, testicular issues, and later headaches and visual problems, ultimately diagnosed through imaging and hormonal tests.
- The patient underwent successful surgery, resulting in significant improvement in hormone levels and symptoms, underlining the importance of considering rare pituitary disorders in patients with atypical hypogonadal symptoms.
Multiple large cystic masses in the pelvic cavity caused by pituitary FSH-secreting adenoma: A clinical lesson.
Asian J Surg
June 2024
Department of Radiology and Surgery, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei Province, 441000, China; Department of Internal Medicine and Clinical Pathology, Hubei Province Clinical Research Center of Parkinson's Disease, Xiangyang Key Laboratory of Movement Disorders, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, P.R.C, Hubei, Xiangyang, Hubei Province, 441000, China. Electronic address:
Clinically functioning gonadotropin-secreting pituitary adenoma.
Endocrinol Diabetes Metab Case Rep
January 2024
Department of Internal Medicine, Endocrine and diabetes division, Adan Hospital, Kuwait.
Article Synopsis
- Gonadotroph adenomas are the most common type of nonfunctional pituitary adenomas, but functioning ones that cause symptoms are quite rare; this article discusses a case of a 42-year-old man diagnosed with a functioning gonadotroph adenoma after an incidental finding of a pituitary mass.
- The patient exhibited elevated follicle-stimulating hormone (FSH) and testosterone levels, underwent transsphenoidal resection of the adenoma, and subsequently saw normalization of hormone levels and improvement in symptoms.
- The findings emphasize the importance of endocrine evaluation for pituitary incidentalomas, the diagnostic challenges posed by functioning gonadotroph adenomas, and the effectiveness of surgery in achieving favorable patient outcomes.
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas.
Endocr Relat Cancer
January 2024
Department of Pathology, Johns Hopkins Hospital, School of Medicine, Baltimore, Maryland, USA.
Cytotoxic T lymphocyte-associated protein 4 (CTLA4), a negative regulator typically expressed on the surface of T lymphocytes, is targeted by immunotherapy in patients with an ever-expanding spectrum of cancers. Characterizing the expression of CTLA4 in the pituitary gland could provide additional rationale for using immune checkpoint inhibitors in pituitary adenoma patients who do not respond to conventional treatments. We assessed the expression of CTLA4 mRNA and protein in a panel of 157 human pituitary glands, 45 collected at autopsy and 112 at surgery.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!